Hyundai Bioscience Co Ltd
KOSDAQ:048410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hyundai Bioscience Co Ltd
Operating Income
Hyundai Bioscience Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Operating Income
-₩18.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Operating Income
₩335.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-8%
|
|
|
Amorepacific Group
KRX:002790
|
Operating Income
₩368B
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-9%
|
|
|
Cosmax Inc
KRX:192820
|
Operating Income
₩195.8B
|
CAGR 3-Years
54%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Operating Income
₩170.7B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-13%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Operating Income
₩239.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
Hyundai Bioscience Co Ltd
Glance View
HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.
See Also
What is Hyundai Bioscience Co Ltd's Operating Income?
Operating Income
-18.2B
KRW
Based on the financial report for Dec 31, 2025, Hyundai Bioscience Co Ltd's Operating Income amounts to -18.2B KRW.
What is Hyundai Bioscience Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-32%
The average annual Operating Income growth rates for Hyundai Bioscience Co Ltd have been 12% over the past three years , -32% over the past five years .
